Method of Treating Malignant Mesothelioma

The present invention relates to a therapeutic agent for malignant mesothelioma comprising a substance which inhibits binding of CD26 to extracellular matrix such as an siRNA targeting CD26 cDNA or an anti-CD26 antibody. The present invention also relates to a method of treating malignant mesothelioma, which comprises administering the substance to a patient in need thereof.

The present invention relates to a therapeutic agent for malignant mesothelioma and a method of treating malignant mesothelioma.

Patents:
US 20,100,135,993

Inventor(s): MORIMOTO CHIKAO [JP]; OHNUMA KEI [JP]; INAMOTO TERUO [JP]

Type of Offer: Sale



« More Medical Patents

---